Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | holo-[acyl-carrier-protein] synthase, putative | 0.0023 | 0.0483 | 0.5 |
Schistosoma mansoni | tripeptidyl-peptidase II (S08 family) | 0.0263 | 1 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0041 | 0.1177 | 1 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0021 | 0.0392 | 0.7405 |
Echinococcus multilocularis | L aminoadipate semialdehyde | 0.0082 | 0.283 | 0.8078 |
Loa Loa (eye worm) | hypothetical protein | 0.0082 | 0.283 | 0.2733 |
Trypanosoma brucei | unspecified product | 0.0034 | 0.0918 | 0.7519 |
Toxoplasma gondii | 4'-phosphopantetheinyl transferase domain-containing protein | 0.0023 | 0.0483 | 1 |
Mycobacterium leprae | conserved hypothetical protein | 0.0023 | 0.0483 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.1177 | 1 |
Loa Loa (eye worm) | POT family protein | 0.0085 | 0.2955 | 0.286 |
Loa Loa (eye worm) | subtilase | 0.0263 | 1 | 1 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0041 | 0.1177 | 0.5 |
Brugia malayi | POT family protein | 0.0085 | 0.2955 | 0.286 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0031 | 0.0785 | 0.6246 |
Echinococcus granulosus | peptidase s8 s53 subtilisin kexin sedolisin | 0.0098 | 0.3472 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0034 | 0.0918 | 0.7519 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.1177 | 1 |
Plasmodium vivax | holo-[acyl-carrier-protein] synthase, putative | 0.0023 | 0.0483 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0023 | 0.0483 | 0.3351 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.1177 | 1 |
Echinococcus granulosus | L aminoadipate semialdehyde | 0.0082 | 0.283 | 0.8078 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0031 | 0.0785 | 0.6246 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.1177 | 1 |
Leishmania major | phosphopantetheinyl transferase-like protein | 0.0023 | 0.0483 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0016 | 0.0216 | 0.0792 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.1177 | 1 |
Echinococcus multilocularis | dna polymerase kappa | 0.0041 | 0.1177 | 0.3128 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0041 | 0.1177 | 1 |
Echinococcus multilocularis | Peptidase S8 S53, subtilisin kexin sedolisin | 0.0098 | 0.3472 | 1 |
Leishmania major | DNA polymerase kappa, putative | 0.0021 | 0.0392 | 0.7405 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.1177 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0023 | 0.0483 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0021 | 0.0392 | 0.2481 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0041 | 0.1177 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0016 | 0.0216 | 0.0792 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0016 | 0.0216 | 0.0792 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0041 | 0.1177 | 1 |
Toxoplasma gondii | 4'-phosphopantetheinyl transferase superfamily protein | 0.0023 | 0.0483 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.1177 | 1 |
Giardia lamblia | DINP protein human, muc B family | 0.0021 | 0.0392 | 0.5 |
Onchocerca volvulus | 0.0082 | 0.283 | 0.5 | |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0041 | 0.1177 | 0.5 |
Brugia malayi | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | 0.0082 | 0.283 | 0.2733 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0041 | 0.1177 | 1 |
Treponema pallidum | 4'-phosphopantetheinyl transferase | 0.0023 | 0.0483 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | 4'-phosphopantetheinyl transferase | 0.0023 | 0.0483 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0041 | 0.1177 | 1 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0021 | 0.0392 | 0.7405 |
Echinococcus granulosus | dna polymerase kappa | 0.0041 | 0.1177 | 0.3128 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.1177 | 1 |
Chlamydia trachomatis | holo [acyl-carrier protein] synthase | 0.0023 | 0.0483 | 0.5 |
Schistosoma mansoni | aminoadipate-semialdehyde dehydrogenase | 0.0082 | 0.283 | 0.2733 |
Mycobacterium tuberculosis | holo-[acyl-carrier protein] synthase AcpS (holo-ACP synthase) (CoA:APO-[ACP]pantetheinephosphotransferase) (CoA:APO-[acyl-carrie | 0.0023 | 0.0483 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.0785 | 0.0661 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.1177 | 1 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0041 | 0.1177 | 1 |
Brugia malayi | polk-prov protein | 0.0031 | 0.0785 | 0.0661 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0041 | 0.1177 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 44.2 uM | Inhibition of human recombinant SIRT1 | ChEMBL. | 19419202 |
Inhibition (binding) | = 12.7 % | Inhibition of human recombinant SIRT2 at 60 uM | ChEMBL. | 19419202 |
Inhibition (binding) | = 36.1 % | Inhibition of human recombinant SIRT2 expressed in Escherichia coli at 50 uM incubated at 37 degC for 2 hrs by Fluor de Lys fluorescence assay | ChEMBL. | 21306905 |
Inhibition (binding) | = 83.2 % | Inhibition of human recombinant SIRT1 at 60 uM | ChEMBL. | 19419202 |
Inhibition (binding) | = 83.2 % | Inhibition of human recombinant SIRT1 expressed in Escherichia coli at 50 uM incubated at 37 degC for 2 hrs by Fluor de Lys fluorescence assay | ChEMBL. | 21306905 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.